Taniyama, Yoshiaki
Morishita, Ryuichi
Article History
First Online: 24 November 2016
Competing interests
: The Department of Clinical Gene Therapy is sponsored by Rohto, Fancl, Saisei Mirai, Novartis, Boehringer Ingelheim, Shionogi and Anges MG as an endowed chair and funded research department. The commissioned research funds were supported by Rohto, Fancl, Saisei Mirai, Novartis, Boehringer Ingelheim, Shionogi and Anges MG. The grants and endowment were supported by Astellas, MSD, Daiichi-Sankyo, Tanabe-Mitsubishi, Nikko, Takeda, Novartis, Anges MG, POC Clinical Research and Bayer. The lecture honoraria for RM was disbursed by Takeda, Boehringer Ingelheim, Daiichi-Sankyo, Astellas, Tanabe-Mitsubishi, Shionogi, MSD, Novartis, AstraZeneca and Bayer. The remaining author declares no conflict of interests.
Free to read: This content has been made available to all.